Stay updated on Ivosidenib and Chemo Combo for IDH1-Mutant AML Clinical Trial
Sign up to get notified when there's something new on the Ivosidenib and Chemo Combo for IDH1-Mutant AML Clinical Trial page.

Latest updates to the Ivosidenib and Chemo Combo for IDH1-Mutant AML Clinical Trial page
- Check4 days agoChange DetectedThe History page now shows the addition of Revision: v3.3.4 and the removal of Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe record history now includes a new revision entry (v3.3.3) and removes the previous revision (v3.3.2) and the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check54 days agoChange DetectedRevision history now shows an added entry for v3.3.2 and removal of v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedNotice about government funding and operating status has been removed; overall study record content and version history remain unchanged.SummaryDifference0.8%

- Check76 days agoChange DetectedVersion 4 (2025-01-09) updates the Record History with Recruitment Status and Study Status changes, reflecting the current state of the trial.SummaryDifference0.1%

- Check104 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference13%

Stay in the know with updates to Ivosidenib and Chemo Combo for IDH1-Mutant AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ivosidenib and Chemo Combo for IDH1-Mutant AML Clinical Trial page.